Integrative Health Technologies, Inc. (IHTI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2009 | 38.69 Thousand USD | 0.0% |
| 2006 | -37.18 Thousand USD | 32.6% |
| 2005 | -55.17 Thousand USD | 97.81% |
| 2004 | -2.81 Million USD | -368.45% |
| 2003 | -455.6 Thousand USD | -3558.44% |
| 2002 | -16.71 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2009 FY | - USD | 0.0% |
| 2007 Q2 | 151.8 Thousand USD | 236.7% |
| 2007 Q1 | -111.05 Thousand USD | -751.2% |
| 2007 Q3 | 33.23 Thousand USD | -78.11% |
| 2006 Q1 | -62.4 Thousand USD | -112.09% |
| 2006 FY | - USD | 32.6% |
| 2006 Q4 | -13.04 Thousand USD | 84.26% |
| 2006 Q3 | -82.87 Thousand USD | 94.69% |
| 2006 Q2 | -1.55 Million USD | -2399.35% |
| 2005 Q1 | -431.64 Thousand USD | 63.66% |
| 2005 FY | - USD | 97.81% |
| 2005 Q4 | 516.17 Thousand USD | 13490.6% |
| 2005 Q3 | 3798.00 USD | 116.73% |
| 2005 Q2 | -22.69 Thousand USD | 94.74% |
| 2004 Q4 | -1.18 Million USD | -244.6% |
| 2004 Q2 | -343.48 Thousand USD | 56.19% |
| 2004 Q1 | -784.09 Thousand USD | -89.66% |
| 2004 FY | - USD | -368.45% |
| 2004 Q3 | -344.67 Thousand USD | -0.35% |
| 2003 Q2 | - USD | 100.0% |
| 2003 FY | - USD | -3558.44% |
| 2003 Q1 | -2897.00 USD | -321.31% |
| 2003 Q4 | -413.43 Thousand USD | -240.89% |
| 2003 Q3 | -121.28 Thousand USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2002 Q4 | 1309.00 USD | 169.85% |
| 2002 Q3 | -1874.00 USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Bio Medica Corporation | -1.16 Million USD | 103.327% |
| Arrayit Corporation | -3.07 Million USD | 101.257% |
| Atlantic International Corp. | -5.38 Million USD | 100.718% |
| Biocept, Inc. | -30.24 Million USD | 100.128% |
| Bioqual, Inc. | 3.03 Million USD | 98.724% |
| CardioGenics Holdings Inc | -757.37 Thousand USD | 105.108% |
| DermTech, Inc. | -97.89 Million USD | 100.04% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.91 Billion USD | 99.999% |
| HTG Molecular Diagnostics, Inc. | -20.24 Million USD | 100.191% |
| iMD Companies, Inc. | -154.65 Thousand USD | 125.016% |
| IDenta Corp. | 71.58 Thousand USD | 45.954% |
| Interpace Biosciences, Inc. | 3.83 Million USD | 98.992% |
| InVitro International | 6680.00 USD | -479.192% |
| Lumos Diagnostics Holdings Limited | -5.43 Million USD | 100.712% |
| Many Bright Ideas Technologies Inc. | -12.13 Thousand USD | 418.856% |
| Medical Imaging Corp. | -896.74 Thousand USD | 104.315% |
| NovelStem International Corp. | -3.78 Million USD | 101.022% |
| Optigenex Inc. | -1.18 Million USD | 103.26% |
| PharmChem, Inc. | 1.05 Million USD | 96.329% |
| Proteome Sciences plc | -1.13 Million USD | 103.403% |
| Response Genetics, Inc | -19.66 Million USD | 100.197% |
| Rennova Health, Inc. | -234.81 Thousand USD | 116.477% |
| RushNet, Inc. | -614.85 Thousand USD | 106.293% |
| ScreenPro Security Inc. | -3.43 Million USD | 101.126% |
| Stella Diagnostics Inc. | -5.7 Million USD | 100.678% |
| StageZero Life Sciences Ltd. | -10.27 Million USD | 100.377% |
| Todos Medical Ltd. | -9.39 Million USD | 100.412% |